192 related articles for article (PubMed ID: 21388061)
1. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study.
Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM
Tumori; 2010; 96(6):971-7. PubMed ID: 21388061
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study.
Ma W; Deng Y; Zhou L
Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):258-63. PubMed ID: 15997921
[TBL] [Abstract][Full Text] [Related]
4. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C
Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer.
Yamamichi K; Uehara Y; Kitamura N; Nakane Y; Hioki K
Int J Cancer; 1998 Jun; 79(3):256-62. PubMed ID: 9645347
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
8. [The relationship of expression of CD44v6 with metastasis and prognosis in breast cancer].
Deng Y; Ma W; Fang X; Zheng S
Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):451-2. PubMed ID: 11832082
[TBL] [Abstract][Full Text] [Related]
9. Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study.
Matuschek C; Lehnhardt M; Gerber PA; Poremba C; Hamilton J; Lammering G; Orth K; Budach W; Bojar H; Bölke E; Peiper M
Eur J Med Res; 2014 Feb; 19(1):6. PubMed ID: 24491153
[TBL] [Abstract][Full Text] [Related]
10. CD44 splice variants as prognostic markers in colorectal cancer.
Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
[TBL] [Abstract][Full Text] [Related]
11. HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases.
Sun H; Liu T; Zhu D; Dong X; Liu F; Liang X; Chen C; Shao B; Wang M; Wang Y
Genes Chromosomes Cancer; 2017 Aug; 56(8):598-607. PubMed ID: 28393427
[TBL] [Abstract][Full Text] [Related]
12. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
[TBL] [Abstract][Full Text] [Related]
13. The expression of osteopontin in breast cancer tissue and its relationship with p21ras and CD44V6 expression.
Gao YL; Xing LQ; Ren TJ; Hou JF; Xue Q; Liu C; Han YM
Eur J Gynaecol Oncol; 2016; 37(1):41-7. PubMed ID: 27048108
[TBL] [Abstract][Full Text] [Related]
14. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery.
Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Tan D; Xu K
Diagn Pathol; 2013 Sep; 8():146. PubMed ID: 24004467
[TBL] [Abstract][Full Text] [Related]
16. CD44v6 is not a prognostic factor in primary breast cancer.
Jansen RH; Joosten-Achjanie SR; Arends JW; Volovics A; Hupperets PS; Schouten HC; Hillen HF
Ann Oncol; 1998 Jan; 9(1):109-11. PubMed ID: 9541692
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma].
Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J
Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
[TBL] [Abstract][Full Text] [Related]
19. Cytosol concentrations of CD44 isoforms in breast cancer tissue.
Hefler L; Tempfer C; Haeusler G; Kucera E; Mayerhofer K; Zeillinger R; Reinthaller A; Kainz C
Int J Cancer; 1998 Oct; 79(5):541-5. PubMed ID: 9761127
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours.
Imam H; Eriksson B; Oberg K
Ann Oncol; 2000 Mar; 11(3):295-300. PubMed ID: 10811495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]